Skip to Main Content

UnitedHealth Group Incorporated (NYSE: UNH) Securities Fraud Class Action

View Complaint
COMPANY       UnitedHealth Group Incorporated 
COURT United States District Court for the Southern District of New York
CASE NUMBER 1:25-cv-03799
JUDGE The Hon. Alvin K. Hellerstein
CLASS PERIOD  December 3, 2024 through May 12, 2025
SECURITY TYPE  Securities

LEAD PLAINTIFF DEADLINE IS JULY 11, 2025.

If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.

Case Background:
Class action lawsuits have been filed on behalf of those who purchased or otherwise acquired UnitedHealth Group Incorporated (“UnitedHealth”) (NYSE: UNH) securities between December 3, 2024, and May 12, 2025, inclusive (the “Class Period”).

The complaints allege that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects.  Specifically, Defendants misrepresented and/or failed to disclose that: (1) UnitedHealth engaged in a corporate strategy of denying health coverage in order to boost its profits and share price; (2) this strategy resulted in regulatory scrutiny and public angst against UnitedHealth, which ultimately resulted in the murder of Brian Thompson; (3) animus towards UnitedHealth was such that, subsequent to the murder of Mr. Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy even if they condemned Mr. Thompson’s killing; (4) the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices; (5) notwithstanding the foregoing, UnitedHealth recklessly stuck with the guidance it issued the day before Thompson’s murder, which was unrealistic considering the company’s changing corporate strategies; and (6) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. 
 

What is a Lead Plaintiff?

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case.  Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

Complete this form with your transactions in UnitedHealth Group Incorporated securities between December 3, 2024, and May 12, 2025.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of UnitedHealth Group Incorporated prior to the Class Period?
Are you a current or former employee of UnitedHealth Group Incorporated ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email